)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Praxis Precision Medicines
Praxis Precision Medicines (PRAX) investor relations material
Praxis Precision Medicines AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary10 Jun, 2026
Opening remarks and agenda
Meeting commenced with introductions of board members and executive officers joining virtually.
Independent auditors from Ernst & Young LLP were introduced as present.
Agenda and rules of conduct were made available in the virtual portal, with instructions for voting and Q&A.
Board and executive committee updates
Board members and executive officers were introduced, including the CEO, CFO, COO, General Counsel, and SVP of Finance.
Shareholder proposals
Three proposals were presented: election of Class III directors, ratification of auditors, and advisory approval of executive compensation.
No advance notice of director nominations was received from shareholders.
Analyze the shareholder participation rate
Detail the Class III director term duration
Evaluate the impact of the non-binding pay vote
List Class III directors elected until 2029
Quorum as percentage of shares entitled to vote
Outcome of the advisory vote on executive pay
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Praxis Precision Medicines
- Ulixacaltamide targets a vast unmet need in essential tremor, with a major launch imminent.PRAX
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Ulyxa and relumitragene advance toward launch with strong FDA continuity and broad commercialization plans.PRAXTD Cowen 46th Annual Health Care Conference18 May 2026
- Expanding a diversified royalty portfolio with strong growth, high margins, and disciplined asset selection.PRAXBank of America Global Healthcare Conference 202613 May 2026
- FDA accepted two NDAs; $1.4B cash supports launches and late-stage readouts in 2026.PRAXQ1 20267 May 2026
- Four late-stage CNS assets target blockbuster sales with two PDUFA dates in 2026–2027.PRAXCorporate presentation7 May 2026
- 2026 proxy details director elections, auditor ratification, and strong pay-for-performance alignment.PRAXProxy filing30 Apr 2026
- Votes will be held on director elections, auditor ratification, and executive compensation.PRAXProxy filing30 Apr 2026
- Two NDA filings, strong clinical data, and $1.5B cash position set up multiple 2026 launches.PRAXQ4 202519 Feb 2026
- Late-stage CNS pipeline targets >$20B revenue with strong efficacy, safety, and IP protection.PRAXCorporate presentation19 Feb 2026
Next Praxis Precision Medicines earnings date
Q2 20263 Aug, 2026
Praxis Precision Medicines
Next Praxis Precision Medicines earnings date
Q2 20263 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage